Journal ArticleOPEN ACCESS

The Feasibility of Omega-3 Supplementation Compared to Placebo in the Management of Long COVID Symptoms Among Healthcare Workers: A Randomized Controlled Trial

  • Sarkar A
  • Speiser E
  • Dara S
  • et al.
Cureus (2024)
DOI: 10.7759/cureus.76148
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Background: COVID-19 is known to cause significant multisystem inflammatory responses, leading to symptoms beyond the acute phase of illness. These "long COVID" symptoms affect quality of life and interfere with daily activities. This pilot study looks at the feasibility, tolerability, and safety of omega-3 (docosahexaenoic acid+eicosapentaenoic acid, EPA) among healthcare workers with long COVID symptoms in New Jersey.

Cite

CITATION STYLE

APA

Sarkar, A., Speiser, E., Dara, S., Ogedegbe, C., Chinnery, P., Estanbouli, M.-T., … Parulekar, M. (2024). The Feasibility of Omega-3 Supplementation Compared to Placebo in the Management of Long COVID Symptoms Among Healthcare Workers: A Randomized Controlled Trial. Cureus. https://doi.org/10.7759/cureus.76148

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free